Table 2.
Comparison of patient characteristics based on cancer cachexia and sarcopenia.
| Variable | Cancer Cachexia (%) | Sarcopenia (%) | ||||
|---|---|---|---|---|---|---|
| No (n = 38) |
Yes (n = 194) |
p Value | No (n = 118) |
Yes (n = 114) |
p Value | |
| Age | ||||||
| ≤65 years | 24 (63.2) | 115 (59.3) | 0.655 | 85 (72.0) | 54 (47.4) | 0.000 |
| >65 years | 14 (36.8) | 79 (40.7) | 33 (28.0) | 60 (52.6) | ||
| Gender | ||||||
| Male | 25 (65.8) | 124 (63.9) | 0.826 | 84 (71.2) | 65 (57.0) | 0.024 |
| Female | 13 (34.2) | 70 (36.1) | 34 (28.8) | 49 (43.0) | ||
| Stage | ||||||
| III | 5 (13.2) | 55 (28.4) | 0.051 | 28 (23.7) | 32 (28.1) | 0.450 |
| IV | 33 (86.8) | 139 (71.6) | 90 (76.3) | 82 (71.9) | ||
| Tumor location | ||||||
| Head/neck/uncinate process | 15 (39.5) | 78 (40.2) | 0.933 | 44 (37.3) | 49 (43.0) | 0.376 |
| Body/tail | 23 (60.5) | 116 (59.8) | 74 (62.7) | 65 (57.0) | ||
| Tumor grade | ||||||
| Well diff. | 2 (5.3) | 13 (6.7) | 0.461 | 9 (7.6) | 6 (5.3) | 0.902 |
| Moderately diff. | 18 (47.4) | 67 (34.5) | 43 (36.4) | 42 (36.8) | ||
| Poorly diff. | 7 (18.4) | 36 (18.6) | 22 (18.6) | 21 (18.4) | ||
| Unknown | 11 (28.9) | 78 (40.2) | 44 (37.3) | 45 (39.5) | ||
| Treatment | ||||||
| CS + adj | 3 (7.9) | 21 (10.8) | 0.544 | 13 (11.0) | 11 (9.6) | 0.197 |
| C/T | 27 (71.1) | 145 (74.7) | 82 (69.5) | 90 (78.9) | ||
| C/T + local R/T | 8 (21.1) | 28 (14.4) | 23 (19.5) | 13 (11.4) | ||
| CA19-9 | ||||||
| ≤100 U/mL | 13 (34.2) | 59 (30.4) | 0.644 | 37 (31.4) | 35 (30.7) | 0.914 |
| >100 U/mL | 25 (65.8) | 135 (69.6) | 81 (68.6) | 79 (69.3) | ||
| BMI | ||||||
| ≤22 kg/m2 | 19 (50.0) | 97 (50.0) | 1.000 | 48 (40.7) | 68 (59.6) | 0.004 |
| >22 kg/m2 | 19 (50.0) | 97 (50.0) | 70 (59.3) | 46 (40.4) | ||
| Hemoglobin | ||||||
| ≤12 g/dL | 8 (21.1) | 82 (42.3) | 0.014 | 38 (32.2) | 52 (45.6) | 0.036 |
| >12 g/dL | 30 (78.9) | 112 (57.7) | 80 (67.8) | 62 (54.4) | ||
| Albumin | ||||||
| ≤3.5 g/dL | 9 (23.7) | 60 (30.9) | 0.372 | 23 (19.5) | 46 (40.4) | 0.001 |
| >3.5 g/dL | 29 (76.3) | 134 (69.1) | 95 (80.5) | 68 (59.6) | ||
Abbreviations: diff., differentiation; CS, conversion surgery; adj, adjuvant chemotherapy; C/T, chemotherapy; R/T, radiotherapy; CA19-9, carbohydrate antigen 19-9; BMI, body mass index. The bold value indicates p < 0.05.